These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 25769213)

  • 1. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
    Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Boorjian SA; Carter RE; Geske JR; Callstrom MR; Atwell TD
    J Urol; 2013 Jan; 189(1):30-5. PubMed ID: 23164375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tumour nephrometry score does not correlate with the risk of radiofrequency ablation complications.
    Seideman CA; Gahan J; Weaver M; Olweny EO; Richter M; Chan D; Cadeddu JA
    BJU Int; 2013 Dec; 112(8):1121-4. PubMed ID: 24053576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Cell Carcinoma: Comparison of RENAL Nephrometry and PADUA Scores with Maximum Tumor Diameter for Prediction of Local Recurrence after Thermal Ablation.
    Maxwell AWP; Baird GL; Iannuccilli JD; Mayo-Smith WW; Dupuy DE
    Radiology; 2017 May; 283(2):590-597. PubMed ID: 27875105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between R.E.N.A.L. nephrometry score and survival outcomes in renal tumours.
    Zhang X; Sun Q; Qi Y; Chen Y; Xiong Y; Xi W; Miao Z; Li X; Quan X; Lin J
    Jpn J Clin Oncol; 2024 Mar; 54(3):339-345. PubMed ID: 38117949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates.
    Lane BR; Golan S; Eggener S; Tobert CM; Kahnoski RJ; Kutikov A; Smaldone M; Whelan CM; Shalhav A; Uzzo RG
    J Urol; 2013 Jun; 189(6):2047-53. PubMed ID: 23313207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R.E.N.A.L. Score Outperforms PADUA Score, C-Index and DAP Score for Outcome Prediction of Nephron Sparing Surgery in a Selected Cohort.
    Borgmann H; Reiss AK; Kurosch M; Filmann N; Frees S; Mager R; Tsaur I; Haferkamp A
    J Urol; 2016 Sep; 196(3):664-71. PubMed ID: 27091569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors.
    Osawa T; Hafez KS; Miller DC; Montgomery JS; Morgan TM; Palapattu GS; Weizer AZ; Caoili EM; Ellis JH; Kunju LP; Wolf JS
    J Urol; 2016 Mar; 195(3):574-80. PubMed ID: 26523883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
    Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
    BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery.
    Morgan MA; Roberts NR; Pino LA; Trabulsi EJ; Brown DB; Gomella LG; Lallas CD
    Can J Urol; 2013 Oct; 20(5):6933-7. PubMed ID: 24128832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal ablation of the small renal mass: case selection using the R.E.N.A.L.-Nephrometry Score.
    Reyes J; Canter D; Putnam S; Simhan J; Smaldone MC; Kutikov A; Viterbo R; Chen DY; Uzzo RG
    Urol Oncol; 2013 Oct; 31(7):1292-7. PubMed ID: 22521770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PADUA and R.E.N.A.L. nephrometry scores correlate with perioperative outcomes of robot-assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database.
    Schiavina R; Novara G; Borghesi M; Ficarra V; Ahlawat R; Moon DA; Porpiglia F; Challacombe BJ; Dasgupta P; Brunocilla E; La Manna G; Volpe A; Verma H; Martorana G; Mottrie A
    BJU Int; 2017 Mar; 119(3):456-463. PubMed ID: 27528265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor complexity predicts malignant disease for small renal masses.
    Mullins JK; Kaouk JH; Bhayani S; Rogers CG; Stifelman MD; Pierorazio PM; Tanagho YS; Hillyer SP; Kaczmarek BF; Chiu Y; Allaf ME
    J Urol; 2012 Dec; 188(6):2072-6. PubMed ID: 23083863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?
    Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E
    J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image-guided percutaneous renal cryoablation: preoperative risk factors for recurrence and complications.
    Blute ML; Okhunov Z; Moreira DM; George AK; Sunday S; Lobko II; Vira MA
    BJU Int; 2013 Apr; 111(4 Pt B):E181-5. PubMed ID: 23107011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.